UPS has invested $48 million in 27 temperature-controlled cross-dock facilities across several U.S. and international markets as part of its push to capture more healthcare shipping business. The investment covers both new builds and upgrades to existing locations, including Chicago, Los Angeles, Boston, Miami, and Toronto, with most sites situated in or near airports to enable rapid transfers between air and ground transport. The facilities support temperature-sensitive products like biologics and GLP-1 injectables, and can be used for consolidation or deconsolidation of shipments. UPS's healthcare portfolio generated more than $11 billion in revenue last year, and CEO Carol Tomé has called healthcare an important growth engine with double-digit operating margins. Rival FedEx is also expanding in this space, recently launching a dedicated FedEx Life Sciences organization and reporting nearly $10 billion in healthcare transportation revenue for its 2026 fiscal year.
United Parcel Service IncUPS invests $48M in 27 temperature-controlled cross-dock facilities to capture more healthcare shipping business, a high-growth segment.
FedEx CorporationUPS's $48M investment in temperature-controlled facilities strengthens its healthcare logistics, directly competing with FedEx's Life Sciences expansion.